UK-based Essential Pharma has announced the completion of a 900 million euros ($945 million) financing. The company was ...
Daiichi Sankyo invests $150 million to establish a new antibody-drug conjugate manufacturing facility in Shanghai by 2030, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback